|
Segment Information (Tables)
|
6 Months Ended |
|
Mar. 25, 2012
|
| Notes to Financial Statements [Abstract] |
|
| Revenues and EBT for reportable segments |
The table below presents revenues and EBT for reportable segments (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QCT |
|
QTL |
|
QWI |
|
QSI* |
|
Reconciling
Items*
|
|
Total* |
For the three months ended: |
|
|
|
|
|
|
|
|
|
|
|
March 25, 2012 |
|
|
|
|
|
|
|
|
|
|
|
Revenues |
$ |
3,059 |
|
|
$ |
1,723 |
|
|
$ |
159 |
|
|
$ |
— |
|
|
$ |
2 |
|
|
$ |
4,943 |
|
EBT |
599 |
|
|
1,540 |
|
|
(10 |
) |
|
(99 |
) |
|
(296 |
) |
|
1,734 |
|
March 27, 2011 |
|
|
|
|
|
|
|
|
|
|
|
Revenues |
$ |
1,962 |
|
|
$ |
1,746 |
|
|
$ |
157 |
|
|
$ |
— |
|
|
$ |
5 |
|
|
$ |
3,870 |
|
EBT |
417 |
|
|
1,575 |
|
|
(135 |
) |
|
(45 |
) |
|
(193 |
) |
|
1,619 |
|
|
|
|
|
|
|
|
|
|
|
|
|
For the six months ended: |
|
|
|
|
|
|
|
|
|
|
|
March 25, 2012 |
|
|
|
|
|
|
|
|
|
|
|
Revenues |
$ |
6,143 |
|
|
$ |
3,162 |
|
|
$ |
311 |
|
|
$ |
— |
|
|
$ |
9 |
|
|
$ |
9,625 |
|
EBT |
1,338 |
|
|
2,808 |
|
|
(9 |
) |
|
(133 |
) |
|
(549 |
) |
|
3,455 |
|
March 27, 2011 |
|
|
|
|
|
|
|
|
|
|
|
Revenues |
$ |
4,078 |
|
|
$ |
2,803 |
|
|
$ |
329 |
|
|
$ |
— |
|
|
$ |
7 |
|
|
$ |
7,217 |
|
EBT |
1,057 |
|
|
2,467 |
|
|
(135 |
) |
|
(67 |
) |
|
(234 |
) |
|
3,088 |
|
*As adjusted for discontinued operations (Note 8)
|
| Reconciling items - revenue |
Reconciling items in the previous table were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
March 25,
2012 |
|
March 27, 2011* |
|
March 25,
2012 |
|
March 27, 2011* |
Revenues |
|
|
|
|
|
|
|
Other nonreportable segments |
$ |
3 |
|
|
$ |
5 |
|
|
$ |
11 |
|
|
$ |
9 |
|
Elimination of intersegment revenues |
(1 |
) |
|
— |
|
|
(2 |
) |
|
(2 |
) |
|
$ |
2 |
|
|
$ |
5 |
|
|
$ |
9 |
|
|
$ |
7 |
|
EBT |
|
|
|
|
|
|
|
Unallocated cost of equipment and services revenues |
$ |
(68 |
) |
|
$ |
(17 |
) |
|
$ |
(138 |
) |
|
$ |
(30 |
) |
Unallocated research and development expenses |
(176 |
) |
|
(155 |
) |
|
(339 |
) |
|
(272 |
) |
Unallocated selling, general and administrative expenses |
(168 |
) |
|
(161 |
) |
|
(283 |
) |
|
(246 |
) |
Unallocated investment income, net |
228 |
|
|
216 |
|
|
418 |
|
|
461 |
|
Other nonreportable segments |
(112 |
) |
|
(78 |
) |
|
(207 |
) |
|
(147 |
) |
Intersegment eliminations |
— |
|
|
2 |
|
|
— |
|
|
— |
|
|
$ |
(296 |
) |
|
$ |
(193 |
) |
|
$ |
(549 |
) |
|
$ |
(234 |
) |
*As adjusted for discontinued operations (Note 8)
|
| Reconciling items - EBT |
Reconciling items in the previous table were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
March 25,
2012 |
|
March 27, 2011* |
|
March 25,
2012 |
|
March 27, 2011* |
Revenues |
|
|
|
|
|
|
|
Other nonreportable segments |
$ |
3 |
|
|
$ |
5 |
|
|
$ |
11 |
|
|
$ |
9 |
|
Elimination of intersegment revenues |
(1 |
) |
|
— |
|
|
(2 |
) |
|
(2 |
) |
|
$ |
2 |
|
|
$ |
5 |
|
|
$ |
9 |
|
|
$ |
7 |
|
EBT |
|
|
|
|
|
|
|
Unallocated cost of equipment and services revenues |
$ |
(68 |
) |
|
$ |
(17 |
) |
|
$ |
(138 |
) |
|
$ |
(30 |
) |
Unallocated research and development expenses |
(176 |
) |
|
(155 |
) |
|
(339 |
) |
|
(272 |
) |
Unallocated selling, general and administrative expenses |
(168 |
) |
|
(161 |
) |
|
(283 |
) |
|
(246 |
) |
Unallocated investment income, net |
228 |
|
|
216 |
|
|
418 |
|
|
461 |
|
Other nonreportable segments |
(112 |
) |
|
(78 |
) |
|
(207 |
) |
|
(147 |
) |
Intersegment eliminations |
— |
|
|
2 |
|
|
— |
|
|
— |
|
|
$ |
(296 |
) |
|
$ |
(193 |
) |
|
$ |
(549 |
) |
|
$ |
(234 |
) |
*As adjusted for discontinued operations (Note 8)
|
| Segment assets and reconciling items |
Segment assets and reconciling items were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
March 25,
2012 |
|
September 25,
2011 |
QCT |
$ |
1,784 |
|
|
$ |
1,569 |
|
QTL |
40 |
|
|
36 |
|
QWI |
131 |
|
|
136 |
|
QSI |
1,619 |
|
|
2,386 |
|
Reconciling items |
37,957 |
|
|
32,295 |
|
Total consolidated assets |
$ |
41,531 |
|
|
$ |
36,422 |
|
|